111 Equity Group increases stake in Matinas Biopharma Holdings, Inc.
111 Equity Group, LLC (“111 Equity”) and its principal filed a Schedule 13D with the Securities and Exchange Commission (“SEC”) to disclose that 111 Equity and its principal have collectively accumulated a 5.17% stock ownership stake inMatinas Biopharma Holdings, Inc. (NYSE American: MTNB) (“MTNB”) as of January 2, 2025. Since this filing, the principal of […]